Page last updated: 2024-10-28

ha14-1 and Nasopharyngeal Neoplasms

ha14-1 has been researched along with Nasopharyngeal Neoplasms in 2 studies

ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate: a BH3 mimetic; synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia

Nasopharyngeal Neoplasms: Tumors or cancer of the NASOPHARYNX.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, MK1
Yang, SF1
Lai, JC1
Yeh, KT1
Yang, JS1
Chen, LS1
Chen, HC1
Cheung, HW1
Jin, DY1
Ling, MT1
Wong, YC1
Wang, Q1
Tsao, SW1
Wang, X1

Other Studies

2 other studies available for ha14-1 and Nasopharyngeal Neoplasms

ArticleYear
Expression of bcl-2 correlates with poor prognosis and modulates migration of nasopharyngeal carcinoma cells.
    Clinica chimica acta; international journal of clinical chemistry, 2010, Volume: 411, Issue:5-6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Benzopyrans; Cell Movement; Disease-Free Survival; D

2010
Mitotic arrest deficient 2 expression induces chemosensitization to a DNA-damaging agent, cisplatin, in nasopharyngeal carcinoma cells.
    Cancer research, 2005, Feb-15, Volume: 65, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Benzopyrans; Calcium-Binding Proteins; Caspase 3; Caspase Inhibito

2005